Antihypertensives Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Antihypertensives Market to 2027 - Global Analysis and Forecasts By Therapeutics(Diuretics, Angiotensin, Receptor Blockers, Angiotensin converting enzyme inhibitors, Beta Blockers, Calcium channel blockers, Renin Inhibitors and Vasodilators)

Report Code: TIPRE00003746 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Anti-Hypertensives are drugs used for treating high blood-pressure by measuring it in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery. It pacifies the complications of stroke and myocardial infraction.

MARKET DYNAMICS
The AntiHypertensives market is anticipated to grow in the forecast period owing to driving factors such as changing lifestyle, food habits and stress levels around the world leading to hypertension, high blood pressure, heart failure and others. Nevertheless, the market could face restraints due to increasing threats of genericization and growing competition around the world.

MARKET SCOPE
The "Global Antihypertensive Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antihypertensive market with detailed market segmentation by Therapeutics and geography. The global Antihypertensive market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Antihypertensive market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global AntiHypertensives market is segmented on the basis of Therapeutics. On the basis of Therapeutics the market is segmented as Diuretics, Angiotensin, Receptor Blockers, Angiotensin converting enzyme inhibitors, Beta Blockers, Calcium channel blockers, Renin Inhibitors and Vasodilators.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Antihypertensive market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antihypertensives market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Antihypertensives market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antihypertensives market in these regions.

MARKET PLAYERS
The reports cover key developments in the Antihypertensives Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Antihypertensive Market are anticipated to lucrative growth opportunities in the future with the rising demand for Antihypertensive in the global market. Below mentioned is the list of few companies engaged in the Antihypertensive market.

The report also includes the profiles of key Antihypertensives market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Pfizer Inc
  • Novartis AG
  • Sanofi S.A
  • Merck & Co
  • Boehringer Ingelheim
  • Lupin Limited
  • Johnson & Johnson Ltd
  • Astra Zeneca Plc
  • Daiichi Sankyo Company Limited
  • Ranbaxy Laboratories Limited, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antihypertensives Market - By Therapeutics
1.3.2 Antihypertensives Market - By Region
1.3.2.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ANTIHYPERTENSIVES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIHYPERTENSIVES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIHYPERTENSIVES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIHYPERTENSIVES - GLOBAL MARKET OVERVIEW
6.2. ANTIHYPERTENSIVES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIHYPERTENSIVES MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. DIURETICS
7.3.1. Overview
7.3.2. Diuretics Market Forecast and Analysis
7.4. ANGIOTENSIN
7.4.1. Overview
7.4.2. Angiotensin Market Forecast and Analysis
7.5. RECEPTOR BLOCKERS
7.5.1. Overview
7.5.2. Receptor Blockers Market Forecast and Analysis
7.6. ANGIOTENSIN CONVERTING ENZYME INHIBITORS
7.6.1. Overview
7.6.2. Angiotensin converting enzyme inhibitors Market Forecast and Analysis
7.7. BETA BLOCKERS
7.7.1. Overview
7.7.2. Beta Blockers Market Forecast and Analysis
7.8. CALCIUM CHANNEL BLOCKERS
7.8.1. Overview
7.8.2. Calcium channel blockers Market Forecast and Analysis
7.9. RENIN INHIBITORS AND VASODILATORS
7.9.1. Overview
7.9.2. Renin Inhibitors and Vasodilators Market Forecast and Analysis
8. ANTIHYPERTENSIVES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Antihypertensives Market Overview
8.1.2 North America Antihypertensives Market Forecasts and Analysis
8.1.3 North America Antihypertensives Market Forecasts and Analysis - By Therapeutics
8.1.4 North America Antihypertensives Market Forecasts and Analysis - By Countries
8.1.4.1 United States Antihypertensives Market
8.1.4.1.1 United States Antihypertensives Market by Therapeutics
8.1.4.2 Canada Antihypertensives Market
8.1.4.2.1 Canada Antihypertensives Market by Therapeutics
8.1.4.3 Mexico Antihypertensives Market
8.1.4.3.1 Mexico Antihypertensives Market by Therapeutics
8.1.4.4 US Antihypertensives Market
8.1.4.4.1 US Antihypertensives Market by Therapeutics
8.2. EUROPE
8.2.1 Europe Antihypertensives Market Overview
8.2.2 Europe Antihypertensives Market Forecasts and Analysis
8.2.3 Europe Antihypertensives Market Forecasts and Analysis - By Therapeutics
8.2.4 Europe Antihypertensives Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Antihypertensives Market
8.2.4.1.1 Germany Antihypertensives Market by Therapeutics
8.2.4.2 France Antihypertensives Market
8.2.4.2.1 France Antihypertensives Market by Therapeutics
8.2.4.3 Italy Antihypertensives Market
8.2.4.3.1 Italy Antihypertensives Market by Therapeutics
8.2.4.4 Spain Antihypertensives Market
8.2.4.4.1 Spain Antihypertensives Market by Therapeutics
8.2.4.5 United Kingdom Antihypertensives Market
8.2.4.5.1 United Kingdom Antihypertensives Market by Therapeutics
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Antihypertensives Market Overview
8.3.2 Asia-Pacific Antihypertensives Market Forecasts and Analysis
8.3.3 Asia-Pacific Antihypertensives Market Forecasts and Analysis - By Therapeutics
8.3.4 Asia-Pacific Antihypertensives Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Antihypertensives Market
8.3.4.1.1 Australia Antihypertensives Market by Therapeutics
8.3.4.2 China Antihypertensives Market
8.3.4.2.1 China Antihypertensives Market by Therapeutics
8.3.4.3 India Antihypertensives Market
8.3.4.3.1 India Antihypertensives Market by Therapeutics
8.3.4.4 Japan Antihypertensives Market
8.3.4.4.1 Japan Antihypertensives Market by Therapeutics
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Antihypertensives Market Overview
8.4.2 Middle East and Africa Antihypertensives Market Forecasts and Analysis
8.4.3 Middle East and Africa Antihypertensives Market Forecasts and Analysis - By Therapeutics
8.4.4 Middle East and Africa Antihypertensives Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Antihypertensives Market
8.4.4.1.1 South Africa Antihypertensives Market by Therapeutics
8.4.4.2 Saudi Arabia Antihypertensives Market
8.4.4.2.1 Saudi Arabia Antihypertensives Market by Therapeutics
8.4.4.3 U.A.E Antihypertensives Market
8.4.4.3.1 U.A.E Antihypertensives Market by Therapeutics
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Antihypertensives Market Overview
8.5.2 South and Central America Antihypertensives Market Forecasts and Analysis
8.5.3 South and Central America Antihypertensives Market Forecasts and Analysis - By Therapeutics
8.5.4 South and Central America Antihypertensives Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Antihypertensives Market
8.5.4.1.1 Brazil Antihypertensives Market by Therapeutics
8.5.4.2 Argentina Antihypertensives Market
8.5.4.2.1 Argentina Antihypertensives Market by Therapeutics
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. ANTIHYPERTENSIVES MARKET, KEY COMPANY PROFILES
10.1. PFIZER INC
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. NOVARTIS AG
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. SANOFI S.A
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. MERCK & CO
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. BOEHRINGER INGELHEIM
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. LUPIN LIMITED
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. JOHNSON & JOHNSON LTD
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. ASTRA ZENECA PLC
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. DAIICHI SANKYO COMPANY LIMITED
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. RANBAXY LABORATORIES LIMITED, INC
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc
2. Novartis AG
3. Sanofi S.A
4. Merck & Co
5. Boehringer Ingelheim
6. Lupin Limited
7. Johnson & Johnson Ltd
8. Astra Zeneca Plc
9. Daiichi Sankyo Company Limited
10. Ranbaxy Laboratories Limited, Inc
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book